Sanofi hires Novartis veteran as chief medical officernews2025-08-26T17:28:03+00:00August 26th, 2025|Endpoints News|
Akeso says its PD-1xVEGF hit OS significance in China studynews2025-08-26T16:41:10+00:00August 26th, 2025|Endpoints News|
Regeneron’s rare disease drug succeeds in Phase 3 studynews2025-08-26T15:52:53+00:00August 26th, 2025|Endpoints News|
Lilly plans GLP-1 pill filing after trial success in obesity and diabetesnews2025-08-26T10:45:53+00:00August 26th, 2025|Endpoints News|
BARDA awards nearly $20M to flu vaccine maker Osivaxnews2025-08-26T09:00:23+00:00August 26th, 2025|Endpoints News|
HHS winds down decades-old pediatric brain cancer collaborationnews2025-08-25T19:39:28+00:00August 25th, 2025|Endpoints News|
Argenx’s Vyvgart clears Phase 3 in new subset of myasthenia gravis patientsnews2025-08-25T17:37:23+00:00August 25th, 2025|Endpoints News|
Akeso touts Phase 3 wins for two separate inflammatory drugsnews2025-08-25T15:02:31+00:00August 25th, 2025|Endpoints News|
Merck looks to modest HIV business as a $5B underdognews2025-08-25T14:15:34+00:00August 25th, 2025|Endpoints News|
OpenAI, Retro Bio detail results of AI model for proteinsnews2025-08-22T15:00:08+00:00August 22nd, 2025|Endpoints News|
